Miyanaga, A., Nagashima, H., Utsumi, Y., Fukuhara, T., Suzuki, A., Seike, M., Azuma, K., Kisohara, A., Sugisaka, J., Asahina, H., Tanaka, H., Kanemaru, R., Miyauchi, E., Furuya, N., Sato, H., Nakashima, K., Sakai, K., Nishio, K., Takahashi, F., Maemondo, M. (2025). Final results of afatinib plus chemotherapy with genomic profiling in osimertinib-refractory EGFR-mutant NSCLC: NEJ025B.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8596